Lupin bets big on cardiac tech

Lupin is expanding its digital business with its cardiac rehab platform and partnering with hospitals and insurers

- Jessica Jani

Lupin's digital therapeutics arm that focuses on cardiac rehabilitation and care, has doubled its patient base to 10,000 in the past year and expects to grow exponentially this financial year.

The platform is growing its patient base through new partnerships with larger hospitals, as well as insurers. It has also expanded its offerings beyond just post-surgery rehabilitation, to prevention programmes for at-risk individuals, Lupin Digital Health's chief executive Sidharth Srinivasan told Mint in an interview.

Lupin is expanding its offerings beyond medicines, with an aggressive push to its digital therapeutics platform focused on cardiac care.

"We are a prescription product," Srinivasan told Mint. "(This) means the hospital or the doctor prescribes it (the platform) to the patient...and the patient then decides to take it up,"

Srinivasan said.